EUVIMEDEUVIMED entdecken
Crossref

Melittin as a Potential Inhibitor of HIV‐1 Reverse Transcriptase: An in Silico Approach

Sukru Akmese, Cemal Sandallı, Halbay Turumtay, Gokhan Zengin, Abdullahi Ibrahim Uba, Mehmet Veysi Cetiz

ChemistrySelect · 2026-10 · 11 (40)

DOI: 10.1002/slct.74965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 26.10.2026. Verfasst von Sukru Akmese und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melittin, a major amphipathic component of honey bee venom, is well known for its broad antimicrobial activity and has been implicated in the disruption of viral proteins. In this study, we investigated the potential of short melittin‐derived fragments as inhibitors of HIV‐1 reverse transcriptase (RT) through the implementation of an integrated in silico workflow. The 26‐residue melittin was systematically fragmented into 4‐14‐residue peptides, yielding a non‐redundant set of 168 unique melittin‐derived fragments. Docking calculations were performed and eight peptide‐RT complexes were subsequently selected for molecular dynamics (MD) simulations and analysed with respect to RMSD, RMSF, hydrogen‐bonding, protein–peptide minimum distance and SASA, followed by MM/GBSA binding free‐energy calculations. A total of 49 peptides attained docking scores ≤ −8.0 kcal/mol, predominantly engaging NNRTI‐site residues Val90, Gly93, Gln161, Lys101, Tyr181, and Met184. MD and MM/GBSA analyses showed complementary profiles, with Mel‐8‐19 exhibiting the most favourable binding free energy, while Mel‐13‐19, Mel‐12‐21 and Mel‐4‐13 showed favourable structural stability. Post‐MD developability screening identified Mel‐4‐13 and Mel‐10‐19 as relatively balanced candidates, whereas Mel‐8‐19 was predicted to be haemolytic. These computational findings identify melittin‐derived fragments for further investigation. Their ability to inhibit HIV‐1 RT remains to be established experimentally.

Zitieren

APA

Akmese, S., Sandallı, C., Turumtay, H., Zengin, G., Uba, A. I., & Cetiz, M. V. (2026). Melittin as a Potential Inhibitor of HIV‐1 Reverse Transcriptase: An in Silico Approach. ChemistrySelect, 11(40). https://doi.org/10.1002/slct.74965

Vancouver

Akmese S, Sandallı C, Turumtay H, Zengin G, Uba AI, Cetiz MV. Melittin as a Potential Inhibitor of HIV‐1 Reverse Transcriptase: An in Silico Approach. ChemistrySelect. 2026;11(40). doi:10.1002/slct.74965

BibTeX
@article{Akmese2026,
  author = {Akmese, Sukru and Sandallı, Cemal and Turumtay, Halbay and Zengin, Gokhan and Uba, Abdullahi Ibrahim and Cetiz, Mehmet Veysi},
  title = {Melittin as a Potential Inhibitor of HIV‐1 Reverse Transcriptase: An in Silico Approach},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {40},
  doi = {10.1002/slct.74965}
}
Kostenlos starten →